Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1434 | 7874 | 32.6 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BILIRUBIN | authKW | 1167398 | 9% | 42% | 712 |
2 | HYPERBILIRUBINEMIA | authKW | 857415 | 5% | 55% | 400 |
3 | KERNICTERUS | authKW | 655905 | 2% | 86% | 196 |
4 | UDP GLUCURONOSYLTRANSFERASE | authKW | 630952 | 4% | 56% | 291 |
5 | GILBERTS SYNDROME | authKW | 576182 | 2% | 85% | 175 |
6 | UGT1A1 | authKW | 532654 | 2% | 71% | 193 |
7 | GLUCURONIDATION | authKW | 373631 | 3% | 38% | 255 |
8 | NEONATAL JAUNDICE | authKW | 353724 | 2% | 58% | 157 |
9 | JAUNDICE | authKW | 243575 | 3% | 25% | 253 |
10 | NEONATAL HYPERBILIRUBINEMIA | authKW | 226584 | 1% | 71% | 82 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pediatrics | 23394 | 19% | 0% | 1525 |
2 | Pharmacology & Pharmacy | 8280 | 21% | 0% | 1636 |
3 | Medical Laboratory Technology | 3246 | 4% | 0% | 284 |
4 | Biochemistry & Molecular Biology | 1295 | 15% | 0% | 1184 |
5 | Gastroenterology & Hepatology | 837 | 4% | 0% | 309 |
6 | Biophysics | 711 | 5% | 0% | 359 |
7 | Obstetrics & Gynecology | 514 | 3% | 0% | 257 |
8 | Toxicology | 502 | 3% | 0% | 251 |
9 | Medicine, Research & Experimental | 266 | 3% | 0% | 268 |
10 | Chemistry, Organic | 237 | 4% | 0% | 334 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOINT TRANSLAT MED | 58568 | 0% | 66% | 23 |
2 | CANADA CHAIR PHARMACOGEN | 31394 | 0% | 90% | 9 |
3 | UBMBE | 31394 | 0% | 90% | 9 |
4 | CONTRACEPT DEVICES NPFPC | 31261 | 0% | 73% | 11 |
5 | SERV BIOQUIM EXPT | 29811 | 0% | 77% | 10 |
6 | CANADA CHAIR PHARMACOGENOM | 27680 | 0% | 71% | 10 |
7 | PHARMACEUT OURCE DISCOVERY | 26215 | 0% | 18% | 38 |
8 | NEONATAL DEV MED | 22324 | 1% | 13% | 44 |
9 | CLIN BIOMED PHYS | 21454 | 0% | 46% | 12 |
10 | STUDI FEGATO | 20229 | 0% | 33% | 16 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 57248 | 4% | 4% | 334 |
2 | LATIN AMERICAN JOURNAL OF PHARMACY | 22124 | 1% | 5% | 118 |
3 | MONATSHEFTE FUR CHEMIE | 14739 | 2% | 3% | 154 |
4 | BIOLOGY OF THE NEONATE | 10463 | 1% | 3% | 84 |
5 | DRUG METABOLISM AND PHARMACOKINETICS | 10325 | 1% | 6% | 44 |
6 | PEDIATRICS | 9795 | 3% | 1% | 223 |
7 | PEDIATRIC RESEARCH | 6859 | 2% | 1% | 129 |
8 | XENOBIOTICA | 5355 | 1% | 2% | 74 |
9 | PHARMACOGENETICS AND GENOMICS | 4867 | 0% | 3% | 38 |
10 | DRUG METABOLISM REVIEWS | 4710 | 0% | 4% | 35 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BILIRUBIN | 1167398 | 9% | 42% | 712 | Search BILIRUBIN | Search BILIRUBIN |
2 | HYPERBILIRUBINEMIA | 857415 | 5% | 55% | 400 | Search HYPERBILIRUBINEMIA | Search HYPERBILIRUBINEMIA |
3 | KERNICTERUS | 655905 | 2% | 86% | 196 | Search KERNICTERUS | Search KERNICTERUS |
4 | UDP GLUCURONOSYLTRANSFERASE | 630952 | 4% | 56% | 291 | Search UDP+GLUCURONOSYLTRANSFERASE | Search UDP+GLUCURONOSYLTRANSFERASE |
5 | GILBERTS SYNDROME | 576182 | 2% | 85% | 175 | Search GILBERTS+SYNDROME | Search GILBERTS+SYNDROME |
6 | UGT1A1 | 532654 | 2% | 71% | 193 | Search UGT1A1 | Search UGT1A1 |
7 | GLUCURONIDATION | 373631 | 3% | 38% | 255 | Search GLUCURONIDATION | Search GLUCURONIDATION |
8 | NEONATAL JAUNDICE | 353724 | 2% | 58% | 157 | Search NEONATAL+JAUNDICE | Search NEONATAL+JAUNDICE |
9 | JAUNDICE | 243575 | 3% | 25% | 253 | Search JAUNDICE | Search JAUNDICE |
10 | NEONATAL HYPERBILIRUBINEMIA | 226584 | 1% | 71% | 82 | Search NEONATAL+HYPERBILIRUBINEMIA | Search NEONATAL+HYPERBILIRUBINEMIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HU, DG , MEECH, R , MCKINNON, RA , MACKENZIE, PI , (2014) TRANSCRIPTIONAL REGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE GENES.DRUG METABOLISM REVIEWS. VOL. 46. ISSUE 4. P. 421 -458 | 292 | 65% | 11 |
2 | ROWLAND, A , MINERS, JO , MACKENZIE, PI , (2013) THE UDP-GLUCURONOSYLTRANSFERASES: THEIR ROLE IN DRUG METABOLISM AND DETOXIFICATION.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 45. ISSUE 6. P. 1121-1132 | 109 | 78% | 128 |
3 | STRASSBURG, C , KALTHOFF, S , EHMER, U , (2008) VARIABILITY AND FUNCTION OF FAMILY 1 URIDINE-5'-DIPHOSPHATE GLUCURONOSYLTRANSFERASES (UGT1A).CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 45. ISSUE 6. P. 485 -530 | 165 | 86% | 24 |
4 | TRIPATHI, SP , BHADAURIYA, A , PATIL, A , SANGAMWAR, AT , (2013) SUBSTRATE SELECTIVITY OF HUMAN INTESTINAL UDP-GLUCURONOSYLTRANSFERASES (UGTS): IN SILICO AND IN VITRO INSIGHTS.DRUG METABOLISM REVIEWS. VOL. 45. ISSUE 2. P. 231-252 | 167 | 76% | 6 |
5 | STINGL, JC , BARTELS, H , VIVIANI, R , LEHMANN, ML , BROCKMOLLER, J , (2014) RELEVANCE OF UDP-GLUCURONOSYLTRANSFERASE POLYMORPHISMS FOR DRUG DOSING: A QUANTITATIVE SYSTEMATIC REVIEW.PHARMACOLOGY & THERAPEUTICS. VOL. 141. ISSUE 1. P. 92-116 | 144 | 65% | 39 |
6 | TUKEY, RH , STRASSBURG, CP , (2000) HUMAN UDP-GLUCURONOSYLTRANSFERASES: METABOLISM, EXPRESSION, AND DISEASE.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 40. ISSUE . P. 581 -616 | 110 | 80% | 910 |
7 | MAISELS, MJ , BALTZ, RD , BHUTANI, VK , NEWMAN, TB , PALMER, H , ROSENFELD, W , STEVENSON, DK , WEINBLATT, HB , (2004) MANAGEMENT OF HYPERBILIRUBINEMIA IN THE NEWBORN INFANT 35 OR MORE WEEKS OF GESTATION.PEDIATRICS. VOL. 114. ISSUE 1. P. 297-316 | 95 | 86% | 683 |
8 | NAGAR, S , REMMEL, RP , (2006) URIDINE DIPHOSPHOGLUCURONOSYLTRANSFERASE PHARMACOGENETICS AND CANCER.ONCOGENE. VOL. 25. ISSUE 11. P. 1659-1672 | 128 | 91% | 107 |
9 | GUILLEMETTE, C , (2003) PHARMACOGENOMICS OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYMES.PHARMACOGENOMICS JOURNAL. VOL. 3. ISSUE 3. P. 136-158 | 144 | 81% | 205 |
10 | RADOMINSKA-PANDYA, A , BRATTON, S , LITTLE, JM , (2005) A HISTORICAL OVERVIEW OF THE HETEROLOGOUS EXPRESSION OF MAMMALIAN UDP-GLUCURONOSYLTRANSFERASE ISOFORMS OVER THE PAST TWENTY YEARS.CURRENT DRUG METABOLISM. VOL. 6. ISSUE 2. P. 141-160 | 148 | 90% | 34 |
Classes with closest relation at Level 2 |